跳至主要内容
临床试验/NCT02372370
NCT02372370已完成1 期

Pretreatments of the Skin to Enhance MAL-induced Protoporphyrin IX (PpIX) Accumulation Prior to Photodynamic Therapy (PDT)

Bispebjerg Hospital0 个研究点目标入组 12 人开始时间: 2014年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
12
主要终点
Protoporphyrin IX (PpIX) fluorescence

研究概览

简要总结

The study investigates the potential of a range of different physical pretreatments to enhance methyl aminolevulinate (MAL)-induced protoporphyrin IX (PpIX) in the skin prior to photodynamic therapy (PDT).

详细描述

The study investigates the potential of a range of different physical pretreatments to enhance methyl aminolevulinate (MAL)-induced protoporphyrin IX (PpIX) in the skin prior to photodynamic therapy (PDT). The pretreatments include: microneedling, sandpaper, curettage, ablative fractional laser and non-ablative fractional laser. 17 treatment areas are mapped on the upper back of the participants. Each participant receives each intervention in a random sequence.

Primary outcome measure: PpIX accumulation after 3 hours incubation with MAL. Secondary outcome measures: pain during treatment and skin reactions.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years or older, healthy, fair skinned (skin type I-III)

排除标准

  • Pregnant women
  • Tattoos, moles or scars in treatment area

研究组 & 干预措施

Interventions

Active Comparator

All participants receive all interventions.

干预措施: Microneedle pretreatment + MAL-PDT (Procedure)

Interventions

Active Comparator

All participants receive all interventions.

干预措施: Sandpaper pretreatment + MAL-PDT (Procedure)

Interventions

Active Comparator

All participants receive all interventions.

干预措施: Curettage pretreatment + MAL-PDT (Procedure)

Interventions

Active Comparator

All participants receive all interventions.

干预措施: Ablative Fractional Laser (AFXL) pretreatment + MAL-PDT (Procedure)

Interventions

Active Comparator

All participants receive all interventions.

干预措施: Non-Ablative Fractional Laser (NAFXL) pretreatment + MAL-PDT (Procedure)

Interventions

Active Comparator

All participants receive all interventions.

干预措施: MAL Control. (Drug)

Interventions

Active Comparator

All participants receive all interventions.

干预措施: Untreated Control (Other)

结局指标

主要结局

Protoporphyrin IX (PpIX) fluorescence

时间窗: Day 0

Protoporphyrin IX (PpIX) fluorescence as measured by a fluorescence camera (Medeikonos PDD/PDT, Medeikonos AB,Gothenburg, Sweden).

次要结局

  • Pain(Day 0)
  • Skin reactions(Day 0, Day 1, Day 3, Day 7)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Merete Haedersdal

Professor, DMSci, MD

Bispebjerg Hospital

相似试验